Behavioral characterization of pentylenetetrazol-induced seizures in the marmoset

Epilepsy and Behavior

Volumn 13, Issue 1, 2008, Pages 70-76

  Bachiega, João C ^a   Blanco, Miriam M ^a   Perez Mendes, Patrícia ^a   Cinini, Simone Maria ^a   Covolan, Luciene ^a   Mello, Luiz E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antiepileptic drugs; Epilepsy model; Marmoset; Pentylenetetrazol

Indexed keywords

CARBAMAZEPINE; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN PROTECTION; CLONIC SEIZURE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; DRUG RESPONSE; FEMALE; MALE; MARMOSET; NONHUMAN; PRIMARY PREVENTION;

ANIMALS; BEHAVIOR, ANIMAL; CALLITHRIX; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LOCOMOTION; MALE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; SEIZURES;

EID: 46549086715     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.02.010     Document Type: Article

References (43)

1. Krall R.L., Penry J.K., Kupferberg H.J., and Swinyard E.A. Antiepileptic drug development: I. History and a program for progress. Epilepsia 19 (1978) 393-408
2. Krall R.L., Penry J.K., White B.G., Kupferberg H.J., and Swinyard E.A. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19 (1978) 409-428
3. Loscher W., and Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2 (1988) 145-181
4. Loscher W., and Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?. Epilepsy Res 17 (1994) 95-134
5. McNamara J.O. Analyses of the molecular basis of kindling development. Psychiatry Clin Neurosci 49 (1995) S175-S178
6. Ben-Ari Y., Tremblay E., Ottersen O.P., and Meldrum B.S. The role of epileptic activity in hippocampal and "remote" cerebral lesions induced by kainic acid. Brain Res 191 (1980) 79-97
7. Turski W.A., Cavalheiro E.A., Schwarz M., Czuczwar S.J., Kleinrok Z., and Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res 9 (1983) 315-335
8. Leite J.P., Bortolotto Z.A., and Cavalheiro E.A. Spontaneous recurrent seizures in rats: an experimental model of partial epilepsy. Neurosci Biobehav Rev 14 (1990) 511-517
9. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 342 (2000) 314-319
10. Porter R.J. Epilepsy: 100 elementary principles (1989), Saunders, London: Philadelphia
11. Burley E.S., and Ferrendelli J.A. Regulatory effects of neurotransmitters on electroshock and pentylenetetrazol seizures. Fed Proc 43 (1984) 2521-2524
12. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs: a comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res 50 (2002) 105-123
13. Meldrum B. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs?. Epilepsy Res 50 (2002) 33-40
14. Sills G.J., Butler E., Thompson G.G., and Brodie M.J. Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models. Seizure 13 (2004) 287-295
15. Mansfield K. Marmoset models commonly used in biomedical research. Comp Med 53 (2003) 383-392
16. Honack D., and Loscher W. Amygdala-kindling as a model for chronic efficacy studies on antiepileptic drugs: experiments with carbamazepine. Neuropharmacology 28 (1989) 599-610
17. Leite J.P., and Cavalheiro E.A. Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats. Epilepsy Res 20 (1995) 93-104
18. Stevenson M.F., and Poole T.B. An ethogram of the common marmoset (Calithrix jacchus jacchus): general behavioural repertoire. Anim Behav 24 (1976) 428-451
19. Schino G., Troisi A., Perretta G., and Monaco V. Measuring anxiety in nonhuman primates: effect of lorazepam on macaque scratching. Pharmacol Biochem Behav 38 (1991) 889-891
20. Racine R.J. Modification of seizure activity by electrical stimulation: II Motor seizure. Electroencephalogr Clin Neurophysiol 32 (1972) 281-294
21. Kliethermes C.L., Finn D.A., and Crabbe J.C. Validation of a modified mirrored chamber sensitive to anxiolytics and anxiogenics in mice. Psychopharmacology 169 (2003) 190-197
22. Jung M.E., Lal H., and Gatch M.B. The discriminative stimulus effects of pentylenetetrazol as a model of anxiety: recent developments. Neurosci Biobehav Rev 26 (2002) 429-439
23. Palit G., Kumar R., Chowdhury S.R., et al. A primate model of anxiety. Eur Neuropsychopharmacol 8 (1998) 195-201
24. Jelenkovic A., Jovanovic M., Ninkovic M., Maksimovic M., Bokonjic D., and Boskovic B. Nitric oxide (NO) and convulsions induced by pentylenetetrazol. Ann NY Acad Sci 962 (2002) 296-305
25. Borowicz K.K., Luszczki J.J., and Czuczwar S.J. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice. Epilepsia 45 (2004) 1176-1183
26. Blanco M.M. Novas estratégias e abordagens terapêuticas para o estudo da epilepsia do lobo temporal em ratos (2005), Universidade Federal de São Paulo-UNIFESP, São Paulo
27. Lian X.Y., Zhang Z., and Stringer J.L. Anticonvulsant and neuroprotective effects of ginsenosides in rats. Epilepsy Res 70 (2006) 244-256
28. King F.A., Yarbrough C.J., Anderson D.C., Gordon T.P., and Gould K.G. Primates. Science 240 (1988) 1475-1482
29. Vellucci S.V. Primate social behavior-anxiety or depression?. Pharmacol Ther 47 (1990) 167-180
30. Kalin N.H. The neurobiology of fear. Sci Am 268 (1993) 94-101
31. Newman J.D., and Farley M.J. An ethologically based, stimulus and gender-sensitive nonhuman primate model for anxiety. Prog Neuro-Psychopharmacol Biol Psychiatry 19 (1995) 677-685
32. Barros M., and Tomaz C. Non-human primate models for investigating fear and anxiety. Neurosci Biobehav Rev 26 (2002) 187-201
33. Smith S.E., Durmuller N., and Meldrum B.S. The non-N -methyl-D-aspartate receptor antagonists GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol 201 (1991) 179-183
34. Chapman A.G., Graham J.L., Patel S., and Meldrum B.S. Anticonvulsant activity of two orally active competitive N -methyl-D-aspartate antagonists, CGP 37849 and CGP 39551, against sound-induced seizures in DBA/2 mice and photically induced myoclonus in Papio papio. Epilepsia 32 (1991) 578-587
35. Stutzmann J.M., Valin A., Bohme G.A., Fardin V., Garret C., and Naquet R. Electrographic studies of the effects of RP 60180, a novel kappa agonist, on the photosensitive baboon Papio papio. Prog Neuro-Psychopharmacol Biol Psychiatry 19 (1995) 687-697
36. Wada J.A. Progressive seizure recruitment in subhuman primates and effect of cerebellar stimulation upon developed vs. developing amygdaloid seizures. Bol Estud Med Biol 28 (1974) 285-301
37. Wada J.A., and Osawa T. Spontaneous recurrent seizure state induced by daily electric amygdaloid stimulation in Senegalese baboons (Papio papio). Neurology 26 (1976) 273-286
38. Barros M., Boere V., Huston J.P., and Tomaz C. Measuring fear and anxiety in the marmoset (Callithrix penicillata) with a novel predator confrontation model: effects of diazepam. Behav Brain Res 108 (2000) 205-211
39. Smith T.E., McGreer-Whitworth B., and French J.A. Close proximity of the heterosexual partner reduces the physiological and behavioral consequences of novel-cage housing in black tufted-ear marmosets (Callithrix kuhli). Horm Behav 34 (1998) 211-222
40. Barnes J.M., Barnes N.M., Costall B., et al. The differential activities of R(+)- and S(-)-zacopride as 5-HT3 receptor antagonists. Pharmacol Biochem Behav 37 (1990) 717-727
41. Costall B., Domeney A.M., Farre A.J., Kelly M.E., Martinez L., and Naylor R.J. Profile of action of a novel 5-hydroxytryptamine 1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset. J Pharmacol Exp Ther 262 (1992) 90-98
42. Cilia J., and Piper D.C. Marmoset conspecific confrontation: an ethologically-based model of anxiety. Pharmacol Biochem Behav 58 (1997) 85-91
43. Perez-Mendes P., Cinini S.M., Medeiros M.A., Tufik S., and Mello L.E. Behavioral and histopathological analysis of domoic acid administration in marmosets. Epilepsia 46 Suppl. 5 (2005) 148-151